Autologous blood cell therapies from pluripotent stem cells

« Previous Next »Blood Reviews
Volume 24, Issue 1 , Pages 27-37, January 2010

Claudia Lengerke
- Division of Hematology and Oncology, University of Tuebingen Medical Center II, 72076 Tuebingen, Germany
- Corresponding author. Address: Division of Hematology and Oncology, University of Tuebingen Medical Center II, Otfried-Mueller-Str. 10, 72076 Tuebingen, Germany. Tel.: +49 7071 2982912; fax: +49 7071 294524.
George Q. Daley
- Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Children’s Hospital, Boston, MA 02115, USA
- Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA
- Manton Center for Orphan Disease Research, Boston, MA 02115, USA
- Harvard Stem Cell Institute, Cambridge, MA 02138, USA
- Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA
- Address: Division of Hematology/Oncology, Children’s Hospital Boston, 300 Longwood Avenue, Boston, MA 02115, USA. Tel.: +1 617 919 2015; fax: +1 617 730 0222.